Also known as Lexapro
Escitalopram (trade names Nexito, Anxiset-E (India), Exodus (Brazil), Esto (Israel), Lexapro, Cipralex, Seroplex, Elicea, Lexamil, Lexam, Entact (Greece), Losita (Bangladesh), Reposil (Chile), Animaxen (Colombia), Esitalo (Australia)), Lexamil (South Africa), is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults and children over 12 years of age with major depressive disorder and generalized anxiety disorder. Escitalopram is the (S)-stereoisomer (enantiomer) of the earlier Lundbeck drug citalopram, hence the name escitalopram. Escitalopram is noted for its high selectivity with serotonin reuptake inhibition. The similarity between escitalopram and citalopram has led to accusations of "evergreening", an accusation that Lundbeck has rejected.Source: Wikipedia
DEA Class 4 meaning a low potential for abuse and low risk of dependence.
Estimated Total Cost: $91.61 for an average of 28 days supply
Patients are most commonly prescribed escitalopram to treat depression, dysthymic disorder, somatization disorder, and rabies.
Patients taking escitalopram most commonly experience side effects like headache, nausea, and mouth dryness.